4-[3,5-bis(trifluoromethyl)benzoyl]-2-hydroxy-3,5-dihydro-2H-1,4-benzoxazepine-8-carboxamide
C19H14F6N2O4 — CID 142799610
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[3,5-bis(trifluoromethyl)benzoyl]-2-hydroxy-3,5-dihydro-2H-1,4-benzoxazepine-8-carboxamide
4-[3,5-bis(trifluoromethyl)benzoyl]-2-hydroxy-3,5-dihydro-2H-1,4-benzoxazepine-8-carboxamide (PubChem CID 142799610) has the molecular formula C19H14F6N2O4 and a molecular weight of 448.32 g/mol. Its IUPAC name is 4-[3,5-bis(trifluoromethyl)benzoyl]-2-hydroxy-3,5-dihydro-2H-1,4-benzoxazepine-8-carboxamide.
Molecular Properties
| Compound Name | 4-[3,5-bis(trifluoromethyl)benzoyl]-2-hydroxy-3,5-dihydro-2H-1,4-benzoxazepine-8-carboxamide |
|---|---|
| PubChem CID | 142799610 |
| Molecular Formula | C19H14F6N2O4 |
| Molecular Weight | 448.32 g/mol |
| Exact Mass | 448.09 |
| IUPAC Name | 4-[3,5-bis(trifluoromethyl)benzoyl]-2-hydroxy-3,5-dihydro-2H-1,4-benzoxazepine-8-carboxamide |
| SMILES | NC(=O)c1ccc2c(c1)OC(O)CN(C(=O)c1cc(C(F)(F)F)cc(C(F)(F)F)c1)C2 |
| InChI | InChI=1S/C19H14F6N2O4/c20-18(21,22)12-3-11(4-13(6-12)19(23,24)25)17(30)27-7-10-2-1-9(16(26)29)5-14(10)31-15(28)8-27/h1-6,15,28H,7-8H2,(H2,26,29) |
| InChIKey | MTKYEVZVEJEYOD-UHFFFAOYSA-N |
| XLogP | 3.18 |
| TPSA | 92.86 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 2 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 448.32 |
| LogP ≤ 5 | 3.18 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 142799610 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.